Health care stocks were declining late Friday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each shedding 0.5%.
The iShares Biotechnology ETF (IBB) rose 0.2%.
In corporate news, Upexi (UPXI) shares soared 152% after the company said it was investigating an instance of possible stock manipulation.
Avalon GloboCare (ALBT) shares jumped past 10% after saying Friday it signed a memorandum of understanding with Qi Diagnostics for the planned co-development of a cannabis breathalyzer.
HCA Healthcare (HCA) shares tumbled 9%. The company's Q3 results missed analyst estimates as Hurricane Helene impacted some of its facilities, while the hospital operator expects a further hurricane-related hit in the ongoing three-month period.
ImmunityBio (IBRX) shares surged 28% after the company reported late Thursday dosing of the first patients in a phase 1 trial that will assess its CAR-NK cellular therapy as a potential treatment for non-Hodgkin's lymphoma.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.